Dyax Corp. (NASDAQ:DYAX)
A biopharmaceutical company focused on the discovery, development and commercialization of novel biotherapeutics for unmet medical needs, with an emphasis on oncology and inflammatory indications.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
Recs
gringo33339
(< 20)
Submitted: 4/26/2013 5:32:29 PM :
Start Price:
$2.73
DYAX Score:
-8.30
Buying opportunity today for this stock which will benefit greatly if LLY sees success in its Ramu pipeline drug candidate.
Recs
Recs
DEWBMW
(< 20)
Submitted: 5/24/2012 12:59:28 AM :
Start Price:
$1.69
DYAX Score:
+30.28
Should break even on cash flow in 2013. Great time to get in. Only company I know that makes a drug for HAE.
Recs
stainsolution
(< 20)
Submitted: 4/9/2012 7:42:31 PM :
Start Price:
$1.57
DYAX Score:
+46.94
Bio play
Recs
zzlangerhans
(99.79)
Submitted: 3/22/2012 3:40:21 AM :
Start Price:
$1.56
DYAX Score:
-50.47
Dyax still claims they will be cash-flow neutral in 2013, but they didn't close out 2011 with any concrete steps towards that goal. Kalbitor revenues barely upticked over the prior quarter, and projected 2012 revenues of 50-54M won't put much of a dent in the quarterly burn, which totaled 14M last quarter. The company added a 20M financing last quarter to build a sizable 75M long-term obligation. The stock has recently been on an upswing but I don't see the momentum being sustained.
Recs
RBuskey106
(< 20)
Submitted: 3/21/2012 11:29:57 AM :
Start Price:
$1.58
DYAX Score:
+47.69
Chart looking good
Recs
portefeuille
(99.78)
Submitted: 3/13/2011 4:59:24 PM :
Start Price:
$1.48
DYAX Score:
+49.75
see this post.
http://caps.fool.com/Blogs/dyax/556162.
Recs
rocknpopstocks
(< 20)
Submitted: 3/11/2011 12:51:19 PM :
Start Price:
$1.57
DYAX Score:
+40.25
Should get some play.
Recs
AndrewGreenBull
(99.12)
Submitted: 11/17/2009 12:12:05 PM :
Start Price:
$3.91
DYAX Score:
-82.10
12/01/2009 FDA Class 2
Recs
wofaintagain
(24.32)
Submitted: 10/15/2009 12:34:34 PM :
Start Price:
$3.22
DYAX Score:
+70.24
until drug approval
Recs
biomedeng
(37.46)
Submitted: 12/31/2007 8:06:33 PM :
Start Price:
$3.87
DYAX Score:
-49.27
The thing to know about Dyax is that the HAE indication for DX-88 is mostly beneficial to get the drug approved for human use. Once DX-88 is approved, it is available for off label indications like CABG, currently in phase II trials. If a couple surgeons see better outcomes with DX-88 in their solutions (and the trials are quite promising), the drug will become very popular very quickly regardless of what the on-label indications are.
Recs
doggetla
(68.49)
Submitted: 10/26/2007 6:57:24 PM :
Start Price:
$4.50
DYAX Score:
-54.39
great bio-tech partners - with lots of "magic beans" in pipeline
Recs
Dwaterman86
(48.15)
Submitted: 10/4/2007 3:39:25 PM :
Start Price:
$3.82
DYAX Score:
+43.90
better off investing in magic beans
Recs
hendrikvanlaar
(< 20)
Submitted: 9/11/2007 4:25:01 AM :
Start Price:
$3.98
DYAX Score:
-53.27
finding a partner to sell their top drug will boost the stock (the successful completion of phase III sent the stock up by 50% in a day, but that didn't last. Make use of it)
Recs
fatcanibal
(32.39)
Submitted: 6/14/2007 4:17:27 PM :
Start Price:
$4.55
DYAX Score:
-56.15
Well organized and focused
Recs
misterp946
(< 20)
Submitted: 5/22/2007 3:41:43 PM :
Start Price:
$4.34
DYAX Score:
-54.08
Hot New Products....stock took a beating....when Genzyme deal feel through...This stock due for a nice come back....sell on announcement
Recs
jgonzz
(< 20)
Submitted: 5/18/2007 3:11:38 PM :
Start Price:
$4.45
DYAX Score:
-56.06
Too many promising projects inside their pipeline.
Recs
carmangar
(< 20)
Submitted: 4/26/2007 9:38:55 PM :
Start Price:
$4.48
DYAX Score:
-58.84
Development of new medicine, pending outcome of further research and medical experimentation.
Recs
majakblue
(76.90)
Submitted: 4/14/2007 3:19:13 PM :
Start Price:
$6.19
DYAX Score:
+77.62
Yeah, yeah, yeah, lets see if any of their candidates get past large scale phase III trials. Lets see if the patients have kidneys and liver left afterwards.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 29 : 1 2 Next »